Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $97.2200 (-0.26%) ($94.3000 - $98.4800) on Thu. Mar. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.78% (three month average) | RSI | 51 | Latest Price | $97.2200(-0.26%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND advances 1.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.39% in a week (0% probabilities). VIXM(-16%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.39% (StdDev 2.78%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
5 Day Moving Average | $99.07(-1.87%) | 10 Day Moving Average | $99.27(-2.07%) | 20 Day Moving Average | $96.88(0.35%) | To recent high | -13.1% | To recent low | 13.3% | Market Cap | $1.562b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |